Epiminder Limited (ASX:EPI)
0.4050
-0.0250 (-5.81%)
At close: May 18, 2026
Epiminder Market Cap
Epiminder has a market cap or net worth of 93.03 million as of May 18, 2026.
Market Cap
93.03M
Enterprise Value
3.54M
Revenue
648.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
Market Cap Chart
Since December 1, 2025, Epiminder's market cap has decreased from 283.42M to 93.03M, a decrease of -67.18%. That is a compound annual growth rate of -91.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 93.03M | -57.84% |
| Dec 31, 2025 | 220.68M | -22.14% |
| Dec 1, 2025 | 283.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 254.56M |
| Aroa Biosurgery | 214.46M |
| EMVision Medical Devices | 162.18M |
| SomnoMed | 124.88M |
| Saluda Medical | 120.97M |
| Lumos Diagnostics Holdings | 115.48M |
| Cleo Diagnostics | 94.43M |
| Compumedics | 55.93M |